Press Releases

05-01-2024	Pliant Therapeutics to Participate in Upcoming Investor Events
04-02-2024	Pliant Therapeutics to Participate in Upcoming Investor Events
03-27-2024	Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International Conference
03-12-2024	Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis
02-27-2024	Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial Results
02-26-2024	Pliant Therapeutics to Participate in Upcoming Investor Conferences
02-07-2024	Pliant Therapeutics to Participate in Upcoming Investor Events
02-04-2024	Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
01-03-2024	Pliant Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference